Skip to main content

Table 3 Univariate and multivariate Cox proportional hazard regression models for overall survival (OS) in PTCL patients

From: The value of a new prognostic model developed by lymphocyte-monocyte ratio and platelet-monocyte ratio in peripheral T-cell lymphoma

Covariate

Univariate analysis

Multivariate analysis

HR

95%CI

p-value

HR

95%CI

p-value

Sex, Male

1.223

0.899–1.662

0.200

   

Age, ≥ 60 years

1.379

1.032–1.843

0.030*

   

IPI, 3–5

3.124

2.265–4.307

 < 0.05*

   

ECOG, 3–5

3.775

2.820–5.054

 < 0.05*

2.351

1.647–3.356

 < 0.05*

Stage, III–IV

7.859

3.862–15.993

 < 0.05*

3.276

1.512–7.099

 < 0.05*

B symptoms

2.101

1.542–2.862

 < 0.05*

   

Bone marrow

3.062

2.297–4.082

 < 0.05*

   

Involvement Albumin, < 35 g/L

2.209

1.656–2.946

 < 0.05*

   

EBV, Positive

1.390

1.024–1.887

0.035*

   

Extra-nodal, > 1

3.207

2.374–4.331

 < 0.05*

1.659

1.125–2.445

0.039*

LY(× 109/L) < 0.8

2.279

1.706–3.045

 < 0.05*

   

MONO(× 109/L) > 1

2.292

1.492–3.523

 < 0.05*

   

PLT(× 109/L) < 83

3.459

2.471–4.841

 < 0.05*

   

Elevated LDH

1.613

1.182–2.200

 < 0.05*

   

Elevated β2-MG

2.159

1.560–2.986

 < 0.05*

   

LMR ≤ 1.68

3.496

2.617–4.669

 < 0.05*

1.751

1.158–2.647

 < 0.05*

PMR ≤ 300

3.947

2.947–5.287

 < 0.05*

1.762

1.201–2.586

 < 0.05*

  1. HR hazard ratio, CI confidence interval
  2. *Significantly different